Company / Operating Cash Flow
BioAge Labs, Inc. Operating Cash Flow History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$81.6M
FY2025
5-year range
-$81.6M / -$37.4M
FY2023-FY2025
Trend
-58.4%
vs FY2024
Sector context
#114 of 216
Health Care
What the data says
At -$82M, BioAge Labs, Inc.'s operating cash flow ranks #114 of 216 in the Health Care sector. Declined from -$37M to -$82M over the past 2 years.
Based on SEC 10-K filings.
-$82M in FY2025.
Declined from -$37M to -$82M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#114 of 216 in Health CareTop 53% of 216This company -$81.6M Sector average $658.7M
▼
-112.4% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow decreased 58.4% year-over-year.
- Ranks #114 out of 216 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.75 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$81.6M | -58.4% |
| FY2024 | -$51.5M | -37.9% |
| FY2023 | -$37.4M | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026